Drug Eluting Stents

Drug Eluting Stents

A growing need for Drug-Eluting Stents (DES), increased number of patients, and a growing acceptance of it as a life saving drug have propelled it exponentially. It is expected that by 2015, the market of DES will be worth around $6 billion. However, decreasing prices have dampened growth.

As discussed, there are various factors that have attracted competition. The most important factor that has contributed towards its growth is its acceptance as an important drug. DES is a scaffold placed in the coronary artery narrowing's to increase blood flow by releasing a drug. The FDA approved them after ...